{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:11:56Z","timestamp":1778199116478,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["IF170661"],"award-info":[{"award-number":["IF170661"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000964","name":"Arthritis National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032194","name":"Confederation of Indian Industry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.biologicals.2026.101883","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:38:59Z","timestamp":1773765539000},"page":"101883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antioxidant excipient\u2013mediated stabilization preserves Fc\u03b3RIIIa binding and ADCC activity of rituximab"],"prefix":"10.1016","volume":"94","author":[{"given":"Aditya","family":"Narvekar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utkarsh","family":"Tathe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amita","family":"Puranik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhalchandra","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhanashree","family":"Jagtap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratnesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5968-1072","authenticated-orcid":false,"given":"Prajakta","family":"Dandekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2026.101883_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ab.2003.12.025","article-title":"Characterizing high-affinity antigen\/antibody complexes by kinetic-and equilibrium-based methods","volume":"328","author":"Drake","year":"2004","journal-title":"Anal Biochem"},{"key":"10.1016\/j.biologicals.2026.101883_bib2","first-page":"7","article-title":"Enhancing antibody-dependent cell-mediated cytotoxicity: a strategy for improving antibody-based immunotherapy","volume":"1","author":"Zahavi","year":"2018","journal-title":"Antib Ther"},{"key":"10.1016\/j.biologicals.2026.101883_bib3","series-title":"Antibody fc:: linking adaptive and innate immunity","author":"Rom\u00e1na","year":"2013"},{"key":"10.1016\/j.biologicals.2026.101883_bib4","unstructured":"Clynes R, Ravetch J V. Fc receptors are required in passive and active immunity to tumor antigens. Proc Natl Acad Sci U S A n.d.;97:10212\u201310216."},{"key":"10.1016\/j.biologicals.2026.101883_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fc\u03b3Rs in immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.biologicals.2026.101883_bib6","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/pro.173","article-title":"Effect of protein structure on deamidation rate in the Fc fragment of an IgG1 monoclonal antibody","volume":"18","author":"Sinha","year":"2009","journal-title":"Protein Sci"},{"key":"10.1016\/j.biologicals.2026.101883_bib7","article-title":"Characterization of IgG1 Fc deamidation at asparagine 325 and its impact on ADCC and Fc\u03b3RIIIa binding","volume":"10","author":"Lu","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.biologicals.2026.101883_bib8","article-title":"ADCC enhancement technologies for next generation therapeutic anti-body","author":"Liu","year":"2009","journal-title":"Trends Bio\/Pharmaceutical Industr"},{"key":"10.1016\/j.biologicals.2026.101883_bib9","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1021\/bp050228w","article-title":"Control of recombinant monoclonal antibody effector function by glycoengineering","volume":"21","author":"Hodoniczky","year":"2005","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.biologicals.2026.101883_bib10","first-page":"423","article-title":"Review of Fc engineering trends and clinical antibodies","volume":"34","author":"Jefferis","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/j.biologicals.2026.101883_bib11","article-title":"Mechanistic overview of Fc-mediated effector functions","author":"DGRT","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.biologicals.2026.101883_bib12","article-title":"Progress and clinical adoption of ADCC-Enhanced antibodies","author":"Stewart","year":"2022","journal-title":"mAbs"},{"key":"10.1016\/j.biologicals.2026.101883_bib13","article-title":"Glycoengineering and ADCC enhancement in approved mAbs","author":"Satoh","year":"2009","journal-title":"mAbs"},{"key":"10.1016\/j.biologicals.2026.101883_bib14","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJMoa1313984","article-title":"Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions","volume":"370","author":"Goede","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biologicals.2026.101883_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10616-010-9330-9","article-title":"Enhancement of antibody production by the addition of Coenzyme-Q10","volume":"63","author":"Konno","year":"2011","journal-title":"Cytotechnology"},{"key":"10.1016\/j.biologicals.2026.101883_bib16","first-page":"163","article-title":"Identification of antioxidants for prevention of peroxide-mediated oxidation of recombinant proteins","volume":"50","author":"Knepp","year":"1996","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1016\/j.biologicals.2026.101883_bib17","first-page":"2537","article-title":"Oxidation and deamidation of monoclonal antibody products: potential impact on stability, biological activity, and efficacy","volume":"110","author":"Gupta","year":"2021","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.biologicals.2026.101883_bib18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/ijms20010194","article-title":"In vivo glycan engineering (kifunensine) improves efficacy of rituximab manufactured in Nicotiana benthamiana","volume":"20","author":"Kommineni","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.biologicals.2026.101883_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-5-64","article-title":"Novel CD20 monoclonal antibodies for lymphoma therapy","volume":"5","author":"Cang","year":"2012","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.biologicals.2026.101883_bib20","first-page":"318","article-title":"Antioxidant activity: the presence and impact of hydroxyl groups in small molecules of natural and synthetic origin, antioxidants\u2014benefits, sources","author":"Al-Mamary","year":"2021","journal-title":"Mech Action"},{"key":"10.1016\/j.biologicals.2026.101883_bib21","article-title":"The role of mass transport limitation and surface heterogeneity in SPR kinetic analysis","author":"Schuck","year":"2010","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.biologicals.2026.101883_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jas.2020.105080","article-title":"DeamiDATE: site-specific deamidation as a tool to assess authenticity of proteins","volume":"115","author":"Rams\u00f8e","year":"2020","journal-title":"J Archaeol Sci"},{"key":"10.1016\/j.biologicals.2026.101883_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jas.2020.105080","article-title":"DeamiDATE 1.0: site-specific deamidation as a tool to assess authenticity of members of ancient proteomes","volume":"115","author":"Rams\u00f8e","year":"2020","journal-title":"J Archaeol Sci"},{"key":"10.1016\/j.biologicals.2026.101883_bib24","article-title":"The accurate prediction of antibody deamidations by computational tools (DeamiDATE and related)","author":"Niu","year":"2024","journal-title":"J Proteome Res"},{"key":"10.1016\/j.biologicals.2026.101883_bib25","article-title":"Oxidation and deamidation of monoclonal antibody products: potential impact on stability","author":"Gupta","year":"2021","journal-title":"Potential Impact Stabil Biol Activity Efficacy"},{"key":"10.1016\/j.biologicals.2026.101883_bib26","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/s19040787","article-title":"High-sensitivity microwave sensor for liquid characterization \u2014 dielectric constant measurement techniques relevant to solution characterization","volume":"19","author":"Zhang","year":"2019","journal-title":"Sensors"},{"key":"10.1016\/j.biologicals.2026.101883_bib27","doi-asserted-by":"crossref","first-page":"17139","DOI":"10.1039\/C8RA00794B","article-title":"Frequency and temperature dependence of dielectric permittivity","volume":"8","author":"Rayssi","year":"2018","journal-title":"RSC Adv"},{"key":"10.1016\/j.biologicals.2026.101883_bib28","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1074\/jbc.M009483200","article-title":"High resolution mapping of the binding site on human IgG1 for Fc\u03b3RI, Fc\u03b3RII, Fc\u03b3RIII, and FcRn","volume":"276","author":"Shields","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biologicals.2026.101883_bib29","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1073\/pnas.0508123103","article-title":"Engineered antibody Fc variants with enhanced effector function","volume":"103","author":"Lazar","year":"2006","journal-title":"Proceed Natl Acad Sci USA"},{"key":"10.1016\/j.biologicals.2026.101883_bib30","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.abb.2012.03.001","article-title":"Strategies for extended serum half-life of protein therapeutics","volume":"526","author":"Kontermann","year":"2012","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.biologicals.2026.101883_bib31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/6179","article-title":"Engineered glycoforms of antibodies with enhanced ADCC","volume":"17","author":"Uma\u00f1a","year":"1999","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.biologicals.2026.101883_bib32","first-page":"27","article-title":"Peptide and protein modification by PEGylation: therapeutic prospects","volume":"60","author":"Veronese","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biologicals.2026.101883_bib33","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1158\/0008-5472.CAN-03-2068","article-title":"Defucosylated chimeric anti-CD20 antibodies with enhanced ADCC","volume":"64","author":"Niwa","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.biologicals.2026.101883_bib34","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1021\/js970143s","article-title":"Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2","volume":"86","author":"Lam","year":"1997","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.biologicals.2026.101883_bib35","first-page":"639","article-title":"Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation","volume":"6","author":"Liu","year":"2014","journal-title":"mAbs"},{"key":"10.1016\/j.biologicals.2026.101883_bib36","first-page":"2400","article-title":"Asparagine deamidation in the complementarity-determining regions of monoclonal antibodies and its impact on antigen binding","volume":"82","author":"Valliere-Douglass","year":"2010","journal-title":"Anal Chem"},{"key":"10.1016\/j.biologicals.2026.101883_bib37","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1002\/rcm.3831","article-title":"Glutamine deamidation of a recombinant monoclonal antibody","volume":"22","author":"Liu","year":"2008","journal-title":"Rapid Commun Mass Spectrom: An Int J Devoted Rapid Dissemin Up-to-the-Min Res Mass Spectrom"},{"key":"10.1016\/j.biologicals.2026.101883_bib38","first-page":"130","article-title":"Structural properties of monoclonal antibody aggregates induced by freeze\u2013thawing and thermal stress","volume":"82","author":"Hawe","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.biologicals.2026.101883_bib39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ab.2003.11.004","article-title":"Kinetic screening of antibodies using biacore \u2014 methods for sensogram interpretation","volume":"325","author":"Canziani","year":"2004","journal-title":"Anal Biochem"},{"key":"10.1016\/j.biologicals.2026.101883_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1099-1352(199909\/10)12:5<293::AID-JMR472>3.0.CO;2-M","article-title":"The influence of transport on the kinetics of binding to surfaces (SPR transport analysis)","author":"Goldstein","year":"1999","journal-title":"J Mol Recogn"},{"key":"10.1016\/j.biologicals.2026.101883_bib41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jsps.2016.07.002","article-title":"An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practice","volume":"25","author":"Salahudeen","year":"2017","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.biologicals.2026.101883_bib42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-1759(98)00092-1","article-title":"The matrix effects on kinetic rate constants of antibody\u2013antigen interactions reflect solvent viscosity","volume":"217","author":"Morgan","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.biologicals.2026.101883_bib43","article-title":"Antioxidant capability and mechanism of action: HAT dominates in many phenolic systems \u2014 DFT & experimental synergy","author":"Romeo","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.biologicals.2026.101883_bib44","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.3390\/ma14081984","article-title":"Recent developments in effective antioxidants: structural features and mechanisms (HAT\/SET\/SPLET)","volume":"14","author":"Parcheta","year":"2021","journal-title":"Materials (MDPI)"},{"key":"10.1016\/j.biologicals.2026.101883_bib45","article-title":"Computational strategies for predicting free radical scavenging and antioxidant mechanisms (HAT, SET-PT, SPLET)","volume":"119","author":"Galano","year":"2019","journal-title":"Int J Quant Chem"},{"key":"10.1016\/j.biologicals.2026.101883_bib46","doi-asserted-by":"crossref","first-page":"17139","DOI":"10.1039\/C8RA00794B","article-title":"Frequency and temperature-dependence of dielectric permittivity and electric modulus studies of the solid solution ca 0.85 Er 0.1 Ti 1\u2212 x Co 4x\/3 O 3 (0\u2264 x\u2264 0.1)","volume":"8","author":"Rayssi","year":"2018","journal-title":"RSC Adv"},{"key":"10.1016\/j.biologicals.2026.101883_bib47","first-page":"369","article-title":"Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides","volume":"23","author":"Geiger","year":"1987","journal-title":"CRC Crit Rev Biochem"},{"key":"10.1016\/j.biologicals.2026.101883_bib48","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.3390\/molecules25122745","article-title":"Recent advances in the chemistry of ellagic acid and its derivatives","volume":"25","author":"Evtyugin","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biologicals.2026.101883_bib49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0753-3322(03)00043-X","article-title":"The importance of glutathione in human disease","volume":"57","author":"Townsend","year":"2003","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.biologicals.2026.101883_bib50","unstructured":"Yin X. Chemical stability and degradation mechanisms of ascorbic acid: a review. [J Name Needed] n.d.;[Volume]:[Start Page]-[End Page]."},{"key":"10.1016\/j.biologicals.2026.101883_bib51","unstructured":"Pinz MP. Uric acid as a dual antioxidant and pro-oxidant: context dependence and mechanisms. [J Name Needed] n.d.;[Volume]:[Start Page]-[End Page]."},{"key":"10.1016\/j.biologicals.2026.101883_bib52","unstructured":"Needed] [Author. ONIOM\/G3B3 and bond dissociation energy (BDE) method comparisons for antioxidant reactivity. [J Name Needed] n.d.;[Volume]:[Start Page]-[End Page]."},{"key":"10.1016\/j.biologicals.2026.101883_bib53","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-018-2467-5","article-title":"Mitigation of oxidation in therapeutic antibody formulations: a biochemical efficacy and safety evaluation of N-acetyl-tryptophan and L-methionine","volume":"35","author":"Dion","year":"2018","journal-title":"Pharm Res"},{"key":"10.1016\/j.biologicals.2026.101883_bib54","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.molimm.2009.02.002","article-title":"Impact of methionine oxidation on the binding of human IgG1 to FcRn and Fc\u03b3 receptors","volume":"46","author":"Bertolotti-Ciarlet","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.biologicals.2026.101883_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-018-2467-5","article-title":"Mitigation of oxidation in therapeutic antibody formulations: a biochemical efficacy and safety evaluation of N-acetyl-tryptophan and","volume":"35","author":"Dion","year":"2018","journal-title":"Pharm Res"},{"key":"10.1016\/j.biologicals.2026.101883_bib56","first-page":"2867","article-title":"Impact of oxidation on the structural and functional integrity of monoclonal antibodies","volume":"32","author":"Yang","year":"2015","journal-title":"Pharm Res"},{"key":"10.1016\/j.biologicals.2026.101883_bib57","first-page":"323","article-title":"Oxidation of therapeutic proteins: analytical tools, mechanisms, and mitigation strategies","volume":"29","author":"Gokarn","year":"2011","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.biologicals.2026.101883_bib58","first-page":"2412","article-title":"Impact of oxidation on stability and biological activity of Fc-fusion proteins","volume":"107","author":"Torosantucci","year":"2018","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.biologicals.2026.101883_bib59","first-page":"283","article-title":"Glutathione and ascorbate protect lymphocytes against oxidative stress without altering cytokine activation profiles","volume":"61","author":"Alam","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.biologicals.2026.101883_bib60","first-page":"278","article-title":"Effects of natural polyphenols on immune cells: modulation without direct activation","volume":"8","author":"Chen","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.biologicals.2026.101883_bib61","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1080\/10826076.2012.743724","article-title":"Size-exclusion chromatography for the analysis of protein biotherapeutics and their aggregates","volume":"35","author":"Hong","year":"2012","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"10.1016\/j.biologicals.2026.101883_bib62","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.biologicals.2009.06.001","article-title":"Human antibody Fc deamidation in vivo","volume":"37","author":"Liu","year":"2009","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2026.101883_bib63","unstructured":"Clynes R, Fulda S, Mallett S. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nat Med n.d.;4:322\u2013325."},{"key":"10.1016\/j.biologicals.2026.101883_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010194","article-title":"In vivo glycan engineering via the mannosidase I inhibitor (Kifunensine) improves efficacy of rituximab manufactured in Nicotiana benthamiana plants","volume":"20","author":"Kommineni","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.biologicals.2026.101883_bib65","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/bit.260480511","article-title":"Chemical instability of protein pharmaceuticals: mechanisms of oxidation and strategies for stabilization","volume":"48","author":"Li","year":"1995","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.biologicals.2026.101883_bib66","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.biologicals.2009.06.001","article-title":"Human antibody Fc deamidation in vivo","volume":"37","author":"Liu","year":"2009","journal-title":"Biologicals"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105626000114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105626000114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T23:57:27Z","timestamp":1778198247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105626000114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":66,"alternative-id":["S1045105626000114"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2026.101883","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antioxidant excipient\u2013mediated stabilization preserves Fc\u03b3RIIIa binding and ADCC activity of rituximab","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2026.101883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101883"}}